Exhibits

Two days later, the nurse completes an assessment of the client. Which assessment findings indicate that the client has stabilized? Select all that apply.

A. "We should be sure to start our daughter on birth control pills." This statement is not directly related to LHRH treatment for precocious sexual development. The primary goal of LHRH treatment is to delay sexual development, and birth control pills are typically not necessary for this purpose.

B. "Sexual maturity differences between my daughter and her peers will disappear within a few years."
In a case of precocious sexual development, treatment with luteinizing hormone-releasing hormone (LHRH) is often used to delay sexual development and slow down the maturation process. It is not typically a lifelong treatment. The primary goal is to allow the child to develop at a more typical pace, so they can catch up with their peers and avoid the psychosocial challenges associated with early sexual maturity. Therefore, the statement in option B indicates a correct understanding of the treatment, as it recognizes that the differences in sexual maturity between the child and her peers should diminish over time.

C. "Our daughter will be on this hormone treatment the rest of her life." This statement is not accurate. LHRH treatment is usually a temporary measure to delay sexual development. It is not a lifelong treatment.

D. "We should encourage her to dress in clothing that suits her sexual maturity level." While this is a consideration for supporting a child with precocious sexual development, the primary treatment aspect is the LHRH therapy itself, which is aimed at delaying sexual development. This statement does not directly address the treatment process.

A. Advising the mother that overuse of albuterol may cause chronic bronchitis is not accurate. Chronic bronchitis is a long-term condition primarily related to smoking or other irritants and is not typically associated with the appropriate use of albuterol as a bronchodilator.

B. Assuring the mother that she is using the medication correctly is not the best response, as it does not address the need for asthma management and education on the proper use of medications and when to seek medical attention.

C. Recommending that the mother bring the child in for immediate evaluation is not necessary if the child's asthma symptoms are being effectively managed with albuterol. However, the child should have an asthma action plan and regular follow-up with a healthcare provider for asthma management.

D Confirm that the medication helps to reduce airway inflammation.

Albuterol is a beta-adrenergic agonist bronchodilator commonly used in the treatment of asthma. It helps to open the airways by relaxing the smooth muscles in the bronchi, making it easier for the child to breathe during an asthma attack. Albuterol does not treat airway inflammation, but it is used to provide quick relief from bronchoconstriction.

The primary role of albuterol is to provide quick relief from acute bronchoconstriction during an asthma attack. It is not a medication for reducing airway inflammation, but it can be used in conjunction with other asthma medications that address inflammation, as prescribed by a healthcare provider. The nurse should educate the mother on the appropriate use of albuterol and the importance of asthma management under the guidance of a healthcare provider.